A sleep study (polysomnography, PSG) is an overnight monitoring of sleep to diagnose sleep disorders, primarily sleep apnea. Two main types – in-lab polysomnography (PSG) is comprehensive overnight study at sleep lab; multiple sensors attached (brain waves/EEG, eye movements, muscle activity, breathing flow and effort, chest/abdomen movement, blood oxygen, heart rhythm, leg movements); video monitoring; sleep technician supervises; gold standard. Home sleep apnea test (HSAT) is simpler portable device; measures breathing, oxygen, heart rate; less comprehensive than PSG; more accessible and lower cost; reasonable for most uncomplicated sleep apnea cases. Information collected – sleep stages, breathing patterns, blood oxygen, heart rate, leg movements, snoring, apneas (breathing stops), hypopneas (shallow breaths). Diagnosis – apnea-hypopnea index (AHI) – events per hour of sleep. AHI categories – normal (less than 5), mild (5-14), moderate (15-29), severe (30+). For diabetes patients – screening recommended given very high prevalence. Major and undertreated comorbidity. Prevalence in type 2 diabetes – about 70% have obstructive sleep apnea (OSA); 50% have moderate to severe OSA; only 25% are diagnosed and treated. Bidirectional relationship – OSA worsens diabetes (insulin resistance, glucose control), and diabetes makes OSA worse (obesity, autonomic neuropathy). Effects of untreated OSA on diabetes – worse insulin resistance and glycemic control (mechanisms include intermittent hypoxia, sleep fragmentation, sympathetic activation); higher A1C (studies show 0.5-1.0% higher A1C in untreated OSA); more cardiovascular disease (already main cause of death in diabetes, OSA adds significant risk); higher blood pressure; higher mortality; more diabetic complications; daytime fatigue (affects self-management); higher hypoglycemia risk (sleep disturbance affects awareness). Treatment – CPAP (most effective), weight loss, oral appliances, surgery in some cases. CPAP adherent use shows modest A1C improvement, BP improvement, daytime function improvement. American Diabetes Association recommends consideration of sleep apnea screening for adults with type 2 diabetes given high prevalence. Specific indications – symptoms of OSA (loud snoring witnessed by partner, witnessed apneas – breathing stops, gasping/choking during sleep, excessive daytime sleepiness, morning headaches, dry mouth on waking); STOP-BANG screening questions; resistant hypertension; uncontrolled diabetes despite good adherence; heart failure or atrial fibrillation; stroke history; pulmonary hypertension. Many adults with diabetes go years undiagnosed – low threshold for screening recommended.
Sleep Apnea in Diabetes
| Statistic | Finding |
|---|---|
| OSA prevalence in T2D | ~70% |
| Moderate-severe OSA in T2D | ~50% |
| Diagnosed and treated | ~25% |
| Untreated OSA effect on A1C | +0.5-1.0% higher |
| OSA association with CV death | Substantially increased |
| OSA association with hypertension | Strong |
AHI Severity Categories
| AHI (events/hour) | Severity | Action |
|---|---|---|
| Less than 5 | Normal | No treatment for OSA |
| 5-14 | Mild OSA | Lifestyle, oral appliance, sometimes CPAP |
| 15-29 | Moderate OSA | CPAP recommended |
| 30+ | Severe OSA | CPAP strongly recommended |
STOP-BANG Screening
- Snoring loudly? (Heard through closed door, partner complaint)
- Tired during day? (Daytime sleepiness)
- Observed apneas? (Partner witnessed breathing stops)
- Pressure (high blood pressure)?
- BMI greater than 35?
- Age over 50?
- Neck circumference larger than 16 inches?
- Gender male?
- 3+ “yes” – high risk; consider testing.
OSA Symptoms
- Loud snoring (especially with pauses).
- Witnessed apneas – breathing stops.
- Gasping or choking during sleep.
- Excessive daytime sleepiness.
- Morning headaches.
- Dry mouth on waking.
- Restless sleep (frequent movements).
- Difficulty concentrating during day.
- Mood changes (irritability, depression).
- Decreased libido or sexual dysfunction.
- Nocturia (waking to urinate).
- Falling asleep while driving or working.
- Memory problems.
OSA Effects on Diabetes
- Worse insulin resistance and glucose control.
- Higher A1C (0.5-1.0% higher in untreated OSA).
- More cardiovascular disease.
- Higher blood pressure (often resistant).
- Higher mortality.
- More diabetic complications (retinopathy, neuropathy, nephropathy).
- Daytime fatigue affecting self-management.
- Higher hypoglycemia risk (impaired awareness).
- Worse quality of life.
- Higher healthcare costs.
Treatment Options
- CPAP (continuous positive airway pressure) – most effective; nightly mask.
- BiPAP (bilevel) – for some patients.
- APAP (auto-titrating CPAP) – most common modern device.
- Oral appliances (mandibular advancement) – for mild-moderate OSA.
- Weight loss – significant benefit; bariatric surgery in some cases.
- Positional therapy – back-sleeping causes OSA in some.
- Surgery – uvulopalatopharyngoplasty (UPPP), Inspire hypoglossal stimulation.
- Sleep hygiene improvements.
- Avoid alcohol before bed.
- Treat nasal congestion.
- Side-sleeping aids.
The Bottom Line
A sleep study (polysomnography, PSG) is an overnight monitoring of sleep to diagnose sleep disorders, primarily sleep apnea. Two main types – in-lab polysomnography (comprehensive overnight study at sleep lab; multiple sensors; gold standard) and home sleep apnea test (HSAT – simpler portable device; reasonable for most uncomplicated cases). Information collected – sleep stages, breathing patterns, blood oxygen, heart rate, leg movements, snoring, apneas, hypopneas. Diagnosis – apnea-hypopnea index (AHI) – events per hour of sleep. AHI categories – normal (less than 5), mild (5-14), moderate (15-29), severe (30+). Major and undertreated comorbidity in diabetes. Prevalence in type 2 diabetes – about 70% have obstructive sleep apnea (OSA); 50% have moderate to severe OSA; only 25% are diagnosed and treated. Bidirectional relationship – OSA worsens diabetes (insulin resistance, glucose control), and diabetes makes OSA worse (obesity, autonomic neuropathy). Effects of untreated OSA on diabetes – worse insulin resistance and glycemic control; higher A1C (0.5-1.0% higher); more cardiovascular disease; higher blood pressure; higher mortality; more diabetic complications; daytime fatigue; higher hypoglycemia risk. American Diabetes Association recommends consideration of sleep apnea screening for adults with type 2 diabetes given high prevalence. Specific indications – symptoms of OSA (loud snoring, witnessed apneas, gasping/choking during sleep, excessive daytime sleepiness, morning headaches); STOP-BANG screening (3+ “yes” – high risk); resistant hypertension; uncontrolled diabetes despite good adherence; heart failure or atrial fibrillation; stroke history. Many adults with diabetes go years undiagnosed – low threshold for screening recommended. In-lab polysomnography – arrive evening; multiple sensors attached; sleep in private room; technician monitors all night; about 8-10 hours. Home sleep test – simpler kit at home; few sensors. CPAP treatment – if diagnosed; nightly mask worn during sleep; gentle positive air pressure keeps airway open; multiple mask types; results with adherent use – improved sleep quality, daytime function, blood pressure, diabetes control. Alternatives if CPAP intolerant – oral appliances, positional therapy, surgery, weight loss. Compliance tracked by machine; insurance may require 70% use 4+ hours per night. Treatment options – CPAP (most effective), BiPAP, APAP (auto-titrating most common modern device), oral appliances (mandibular advancement for mild-moderate), weight loss (significant benefit), positional therapy, surgery (UPPP, Inspire hypoglossal stimulation), sleep hygiene improvements. For adults with type 2 diabetes – sleep apnea screening should be considered if STOP-BANG positive or symptoms present; untreated OSA worsens diabetes outcomes substantially; CPAP treatment effective and improves diabetes control with adherent use. See our broader sleep apnea and diabetes guide for context.
